A new stem cell therapy has repaired blinding damage to the cornea in 93% of patients in an early clinical trial. The cornea ...

CRISPR gene-editing has improved the vision of patients with a form of blindness in a Phase 1/2 clinical trial. The results give new hope to patients with the condition, and show that CRISPR could ...

Patients with 'blinding' headaches known as Idiopathic Intercranial Hypertension (IIH) could be treated with a GLP-1RA peptide used for type 2 diabetes, a new phase 2 trial has found.

An expanded clinical trial that tested a groundbreaking, experimental stem cell treatment for blinding cornea injuries found the treatment was feasible and safe in 14 patients who were treated and ...

A new stem cell therapy has repaired blinding damage to the cornea in 93% of patients in an early clinical trial. However, severe injuries, such as those caused by chemical burns or infections ...